TABLE 3.
Isolate ID | Production system | Processing stage | MIC (μg/ml)
|
Resistance patternb | Mutationc
|
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
CHL (32)a | CIP (4) | ERY (8) | GEN (16) | NAL (32) | TET (16) | Thr 86 Ile | 23S rRNA gene | ||||
49 | ABF | Nursery | 4 | 0.25 | 8 | 2 | 32 | >32 | ERY NAL TET | − | − |
260 | ABF | Nursery | 8 | 8 | 4 | 8 | >128 | >32 | CIP NAL TET | − | − |
952 | ABF | Finishing | 16 | 2 | >32 | 2 | >128 | >32 | ERY NAL TET | − | − |
966 | ABF | Finishing | 8 | 2 | 16 | 2 | >128 | >32 | ERY NAL TET | − | + |
1005 | ABF | Finishing | 4 | 1 | >32 | 1 | >128 | >32 | ERY NAL TET | − | + |
4075 | ABF | Finishing | 8 | 8 | 4 | 8 | >128 | >32 | CIP NAL TET | − | − |
4076 | ABF | Finishing | 8 | 8 | 4 | 8 | >128 | >32 | CIP NAL TET | − | − |
3804 | ABF | Finishing | 8 | 4 | >32 | 2 | 64 | >32 | CIP ERY NAL TET | − | − |
461 | Conventional | Nursery | 4 | 4 | >32 | 16 | >128 | >32 | CIP ERY GEN NAL TET | − | + |
475 | Conventional | Nursery | 8 | >4 | >32 | 2 | 128 | >32 | CIP ERY NAL TET | + | + |
524 | Conventional | Nursery | 8 | >4 | >32 | 8 | >128 | >32 | CIP ERY NAL TET | + | + |
525 | Conventional | Nursery | 8 | 64 | >32 | 1 | 128 | >32 | CIP ERY NAL TET | + | + |
526 | Conventional | Nursery | 8 | 64 | >32 | 1 | 128 | >32 | CIP ERY NAL TET | + | + |
548 | Conventional | Nursery | 2 | >64 | >32 | 1 | 128 | >32 | CIP ERY NAL TET | + | + |
549 | Conventional | Nursery | 2 | >64 | >32 | 2 | 128 | >32 | CIP ERY NAL TET | + | + |
552 | Conventional | Nursery | 4 | >64 | >32 | 2 | 128 | >32 | CIP ERY NAL TET | + | + |
554 | Conventional | Nursery | 4 | >64 | >32 | 2 | 128 | >32 | CIP ERY NAL TET | + | + |
555 | Conventional | Nursery | 4 | >64 | >32 | 2 | 128 | >32 | CIP ERY NAL TET | + | + |
459 | Conventional | Finishing | 8 | 0.5 | >32 | 1 | 32 | >32 | ERY NAL TET | − | + |
4516 | Conventional | Finishing | 32 | 4 | >32 | 1 | 128 | >32 | CHL CIP ERY NAL TET | − | + |
4517 | Conventional | Finishing | 32 | 4 | >32 | 1 | 128 | >32 | CHL CIP ERY NAL TET | − | + |
Breakpoint level based on C. jejuni ATCC 33560 in μg/ml antimicrobial concentration.
CHL, chloramphenicol; CIP, ciprofloxacin; ERY, erythromycin; GEN, gentamicin; NAL, nalidixic acid; TET, tetracycline.
Point mutations in gyrA and the 23S rRNA genes coding for ciprofloxacin and erythromycin resistance, respectively. All isolates were positive for the tet(O) gene.